Condition: Human Papilloma Virus · Infertility, Female · Sponsor: University Hospital, Brest
The prevalence of the papilloma virus in the general population is 12%. This virus is known to impair male fertility but its impact on female infertility remains uncertain. This is a public health problem since there is a vaccination protocol. Demonstrating the impact of the human papillomavirus on fertility would be an argument in favor of vaccination.
This description comes directly from the study's public registry record.
Sarah BOUEE · 02 98 22 39 70 · sarah.bouee@chu-brest.fr
Anne-Solenn JACAMON · anne-solenn.jacamon@chu-brest.fr
Always discuss trial participation with your own doctor first.
| CHRU de Brest | Brest, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06550531